EUVIMEDEUVIMED entdecken
Open Access

Multiple Comprehensive Analyses Identify Lysine Demethylase KDM as a Potential Therapeutic Target for Pancreatic Cancer

Wan-Jou Shen, Hsuan-Min Kao, Chih-Yang Wang, Rubina Kousar, Jing-Shan Lin, Ching-Chung Ko, Hung-Yun Lin, Hoang Dang Khoa Ta, Gangga Anuraga, Do Thi Minh Xuan, Sachin Kumar, Sanskriti Dey und 2 weitere

International Journal of Medical Sciences · 2024

DOI: 10.7150/ijms.96134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2024. Verfasst von Wan-Jou Shen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Biomedical Sciences, College of Medicine, China Medical University, Taichung 40402, Taiwan. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Jumonji Domain-Containing Histone Demethylases, Biomarkers, Tumor, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic cancer (PC) is a challenging and heterogeneous disease with a high mortality rate. Despite advancements in treatment, the prognosis for PC patients remains poor, with a high chance of disease recurrence. Biomarkers are crucial for diagnosing cancer, predicting patient prognosis and selecting treatments. However, the current lack of effective biomarkers for PC could contribute to the insufficiency of existing treatments. These findings underscore the urgent need to develop novel strategies to fight this disease. This study utilized multiple comprehensive bioinformatic analyses to identify potential therapeutic target genes in PC, focusing on histone lysine demethylases (KDMs). We found that high expression levels of KDM family genes, particularly KDM1A, KDM5A and KDM5B, were associated with improved overall survival in the cohort. Furthermore, the infiltration of various immune cells, including B cells, neutrophils, CD8+ T cells, dendritic cells, and macrophages, was positively correlated with KDM1A, KDM5A, and KDM5B expression. Moreover, MetaCore pathway analysis revealed interesting connections between KDM1A and the cell cycle and proliferation, between KDM5A and DNA damage and double-strand break repair through homologous recombination, and between KDM5B and WNT/β-catenin signaling. These findings suggest that KDM1A, KDM5A and KDM5B may serve as promising biomarkers and therapeutic targets for PC, a disease of high importance due to its aggressive nature and urgent need for novel biomarkers to improve diagnosis and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsJumonji Domain-Containing Histone DemethylasesBiomarkers, TumorGene Expression Regulation, NeoplasticHumansPrognosisComputational BiologyF-Box ProteinsHistone DemethylasesMolecular Targeted TherapyRetinoblastoma-Binding Protein 2Wnt Signaling PathwayCell ProliferationNuclear ProteinsRepressor Proteins

Substanzen

KDM1A protein, humanJumonji Domain-Containing Histone DemethylasesBiomarkers, TumorKDM5B protein, humanKDM5A protein, humanF-Box ProteinsHistone DemethylasesRetinoblastoma-Binding Protein 2Nuclear ProteinsRepressor Proteins

Autor:innen und Institutionen

  • Graduate Institute of Biomedical Sciences, College of Medicine, China Medical University, Taichung 40402, Taiwan.
  • Department of Geriatric, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi City 600566, Taiwan.
  • Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.
  • Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei 11031, Taiwan.
  • TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan.
  • Department of Biological Science and Technology, China Medical University, Taichung 40676, Taiwan.

Zitieren

APA

Shen, W. J., Kao, H. M., Wang, C. Y., Kousar, R., Lin, J. S., Ko, C. C., Lin, H. Y., Ta, H. D. K., Anuraga, G., Xuan, D. T. M., Kumar, S., Dey, S., Ly, N. P., & Wang, W. J. (2024). Multiple Comprehensive Analyses Identify Lysine Demethylase KDM as a Potential Therapeutic Target for Pancreatic Cancer. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.96134

Vancouver

Shen WJ, Kao HM, Wang CY, Kousar R, Lin JS, Ko CC, et al. Multiple Comprehensive Analyses Identify Lysine Demethylase KDM as a Potential Therapeutic Target for Pancreatic Cancer. International Journal of Medical Sciences. 2024. doi:10.7150/ijms.96134

BibTeX
@article{Shen2024,
  author = {Shen, Wan-Jou and Kao, Hsuan-Min and Wang, Chih-Yang and Kousar, Rubina and Lin, Jing-Shan and Ko, Ching-Chung and Lin, Hung-Yun and Ta, Hoang Dang Khoa and Anuraga, Gangga and Xuan, Do Thi Minh and Kumar, Sachin and Dey, Sanskriti and Ly, Ngoc Phung and Wang, Wei-Jan},
  title = {Multiple Comprehensive Analyses Identify Lysine Demethylase KDM as a Potential Therapeutic Target for Pancreatic Cancer},
  journal = {International Journal of Medical Sciences},
  year = {2024},
  doi = {10.7150/ijms.96134}
}
Kostenlos starten →